Profile picture

Doctor Roopinder Sandhu

University of Calgary, Calgary (Canada)
Membership: ESC Professional Member
Follow
Logo ESC

Contributor content

Cost-effectiveness of apixaban vs aspirin for the reduction of thrombo-embolism in high-risk patients with device-detected atrial fibrillation: insights from the ARTESiA trial
Presentation
Cost-effectiveness of apixaban vs aspirin for the reduction of thrombo-embolism in high-risk patients with device-detected atrial fibrillation: insights from the ARTESiA trial
Read more
The current and future total health care costs of atrial fibrillation
Presentation
The current and future total health care costs of atrial fibrillation
Read more
A polygenic risk score predicts atrial fibrillation in patients with coronary artery disease without severe systolic dysfunction.
Presentation
A polygenic risk score predicts atrial fibrillation in patients with coronary artery disease without severe systolic dysfunction.
Read more

ESC 365 is supported by

novartis Explore sponsored resources